Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Controlled, Non-inferiority Phase III Trial of a Group A and C Meningococcal Polysaccharide Vaccine in Healthy Children Aged 2-6 Years

NCT04689191 is registered in ClinicalTrials.gov with Institute of Medical Biology, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT04689191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04689191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Controlled, Non-inferiority Phase III Trial of a Group A and C Meningococcal Polysaccharide Vaccine in Healthy Children Aged 2-6 Years
Lead sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
September 15, 2020
Completion date
September 26, 2021
Enrollment
1,280 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

meningitis, meningococcal